Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention
作者： Jean-Frédéric Colombel
DOI: 10.1093/IBD/IZY150
关键词: Psoriatic arthritis 、 Rheumatoid arthritis 、 Colitis 、 Tofacitinib 、 Inflammatory bowel disease 、 Ulcerative colitis 、 Psoriasis 、 Internal medicine 、 Discontinuation 、 Medicine
摘要: … were observed for patients with UC compared with Crohn’s disease. These differential risks for HZ may be due to the mechanism of action for treatment types, as previously discussed. …
oup.com
sci-hub.se 参考文章(76)
Giovanni Buccoliero, Francesco Resta, Gaetano Lonero, Pietro Loperfido, Chiara Romanelli, Varicella zoster virus encephalitis during treatment with anti-tumor necrosis factor-alpha agent in a psoriatic arthritis patient New Microbiologica. ,vol. 33, pp. 271- 274 ,(2010)
Stephanie R. Bialek, Rafael Harpaz, Craig M. Hales, Ismael Ortega-Sanchez, Update on recommendations for use of herpes zoster vaccine Morbidity and Mortality Weekly Report. ,vol. 63, pp. 729- 731 ,(2014)
Adnan M. Subei, Jeffrey A. Cohen, Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis CNS Drugs. ,vol. 29, pp. 565- 575 ,(2015) , 10.1007/S40263-015-0261-Z
Joana Torres, Saurabh Mehandru, Jean-Frédéric Colombel, Laurent Peyrin-Biroulet, Crohn's disease The Lancet. ,vol. 389, pp. 1741- 1755 ,(2017) , 10.1016/S0140-6736(16)31711-1
Fernando Valenzuela, Kim A Papp, David Pariser, Stephen K Tyring, Robert Wolk, Marjorie Buonanno, Jeff Wang, Huaming Tan, Hernan Valdez, Effects of tofacitinib on lymphocyte sub-populations, CMV and EBV viral load in patients with plaque psoriasis BMC Dermatology. ,vol. 15, pp. 8- 8 ,(2015) , 10.1186/S12895-015-0025-Y
Jeffrey I. Cohen, Herpes Zoster New England Journal of Medicine. ,vol. 369, pp. 255- 263 ,(2013) , 10.1056/NEJMCP1302674
Mark C. Genovese, Ronald F. van Vollenhoven, César Pacheco-Tena, Yanqiong Zhang, Nils Kinnman, VX-509 (Decernotinib), an Oral Selective JAK-3 Inhibitor, in Combination With Methotrexate in Patients With Rheumatoid Arthritis Arthritis & Rheumatism. ,vol. 68, pp. 46- 55 ,(2016) , 10.1002/ART.39473
K L Winthrop, S-H Park, A Gul, M H Cardiel, J J Gomez-Reino, Y Tanaka, K Kwok, T Lukic, E Mortensen, D Ponce de Leon, R Riese, H Valdez, Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis Annals of the Rheumatic Diseases. ,vol. 75, pp. 1133- 1138 ,(2016) , 10.1136/ANNRHEUMDIS-2015-207319
Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infection and Immunity. ,vol. 32, pp. 24- 27 ,(1981) , 10.1128/IAI.32.1.24-27.1981
W. J. Sandborn, Azathioprine: State of the Art in Inflammatory Bowel Disease Scandinavian Journal of Gastroenterology. ,vol. 225, pp. 92- 99 ,(1998) , 10.1080/003655298750027290